journal article Open Access Sep 11, 2019

Transfusion practice in the non-bleeding critically ill: an international online survey—the TRACE survey

View at Publisher Save 10.1186/s13054-019-2591-6
Abstract
Abstract

Background
Over the last decade, multiple large randomized controlled trials have studied alternative transfusion strategies in critically ill patients, demonstrating the safety of restrictive transfusion strategies. Due to the lack of international guidelines specific for the intensive care unit (ICU), we hypothesized that a large heterogeneity in transfusion practice in this patient population exists. The aims of this study were to describe the current transfusion practices and identify the knowledge gaps.


Methods
An online, anonymous, worldwide survey among ICU physicians was performed evaluating red blood cell, platelet and plasma transfusion practices. Furthermore, the presence of a hospital- or ICU-specific transfusion guideline was asked. Only completed surveys were analysed.


Results
Nine hundred forty-seven respondents filled in the survey of which 725 could be analysed. Hospital transfusion protocol available in their ICU was reported by 53% of the respondents. Only 29% of respondents used an ICU-specific transfusion guideline. The reported haemoglobin (Hb) threshold for the general ICU population was 7 g/dL (7–7). The highest reported variation in transfusion threshold was in patients on extracorporeal membrane oxygenation or with brain injury (8 g/dL (7.0–9.0)). Platelets were transfused at a median count of 20 × 109 cells/L IQR (10–25) in asymptomatic patients, but at a higher count prior to invasive procedures (p < 0.001). In patients with an international normalized ratio (INR) > 3, 43% and 57% of the respondents would consider plasma transfusion without any upcoming procedures or prior to a planned invasive procedure, respectively. Finally, doctors with base specialty in anaesthesiology transfused critically ill patients more liberally compared to internal medicine physicians.


Conclusion
Red blood cell transfusion practice for the general ICU population is restrictive, while for different subpopulations, higher Hb thresholds are applied. Furthermore, practice in plasma and platelet transfusion is heterogeneous, and local transfusion guidelines are lacking in the majority of the ICUs.
Topics

No keywords indexed for this article. Browse by subject →

References
21
[1]
Worldwide audit of blood transfusion practice in critically ill patients

Jean-Louis Vincent, Ulrich Jaschinski, Xavier Wittebole et al.

Critical Care 2018 10.1186/s13054-018-2018-9
[2]
Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. 2002;30(8):1765–71 Available from: http://www.ncbi.nlm.nih.gov/pubmed/2163790 . 10.1097/00003246-200208000-00015
[3]
Walsh TS, Stanworth SJ, Prescott RJ, Lee RJ, Watson DM, Wyncoll D, et al. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med. 2010;38(10):1939–46. 10.1097/ccm.0b013e3181eb9d2b
[4]
Whitaker BI, Rajbhandary S, Harris A. 2013 AABB Blood Survey Report. 2013
[5]
Bolton-Maggs PHB. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents. Transfus Med. 2016;26(6):401–5 Available from: http://www.ncbi.nlm.nih.gov/pubmed/27995700 . 10.1111/tme.12380
[6]
Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005;19(1):2–31 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15830325 . 10.1016/j.tmrv.2004.10.001
[7]
Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21(6):327–48. 10.1016/j.blre.2007.07.003
[8]
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care

Paul C. Hébert, George Wells, Morris A. Blajchman et al.

New England Journal of Medicine 1999 10.1056/nejm199902113400601
[9]
Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc. 2002;288(12):1499–507 Available from: http://www.ncbi.nlm.nih.gov/pubmed/12243637 . 10.1001/jama.288.12.1499
[10]
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding

Càndid Villanueva, Alan Colomo, Alba Bosch et al.

New England Journal of Medicine 2013 10.1056/nejmoa1211801
[11]
Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381–91 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25270275 . 10.1056/nejmoa1406617
[12]
Müller MC, Arbous MS, Spoelstra-de Man AM, Vink R, Karakus A, Straat M, et al. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion. 2015;55(1):26–35 quiz 25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24912653 . 10.1111/trf.12750
[13]
Schofield WN, Rubin GL, Dean MG. Appropriateness of platelet, fresh frozen plasma and cryoprecipitate transfusion in New South Wales public hospitals. Med J Aust. 2003;178(3):117–21. 10.5694/j.1326-5377.2003.tb05101.x
[14]
Qureshi H, Lowe D, Dobson P, Grant-Casey J, Parris E, Dalton D, et al. National comparative audit of the use of platelet transfusions in the UK. Transfus Clin Biol. 2007;14(6):509–13. 10.1016/j.tracli.2008.01.002
[15]
Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DLA. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion. 2013;53(5):1050–8. 10.1111/j.1537-2995.2012.03866.x
[16]
Baharoglu MI, Cordonnier C, Salman RAS, de Gans K, Koopman MM, Brand A, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387(10038):2605–13 Available from: https://doi.org/10.1016/S0140-6736(16)30392-0 . 10.1016/s0140-6736(16)30392-0
[17]
Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med 2018;NEJMoa1807320. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1807320 .
[18]
van de Weerdt EK, Peters AL, Goudswaard EJ, Binnekade JM, van Lienden KP, Biemond BJ, et al. The practice of platelet transfusion prior to central venous catheterization in presence of coagulopathy: a national survey among clinicians. Vox Sang. 2017;112(4):343–51. 10.1111/vox.12498
[19]
van de Weerdt EK, Biemond BJ, Zeerleder SS, van Lienden KP, Binnekade JM, Vlaar APJ, et al. Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial. Trials. Trials. 2018;19:1):1–10.
[20]
Durila M, Lukáš P, Astraverkhava M, Beroušek J, Zábrodskỳ M, Vymazal T. Tracheostomy in intensive care unit patients can be performed without bleeding complications in case of normal thromboelastometry results (EXTEM CT) despite increased PT-INR: a prospective pilot study. BMC Anesthesiol. 2015;15(1):1–6 Available from: https://doi.org/10.1186/s12871-015-0073-1 . 10.1186/1471-2253-15-1
[21]
Yang L, Stanworth S, Hopewell S, Doree C, Murphy M. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion. 2012;52(8):1673–86 quiz 1673. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22257164 . 10.1111/j.1537-2995.2011.03515.x
Metrics
57
Citations
21
References
Details
Published
Sep 11, 2019
Vol/Issue
23(1)
License
View
Cite This Article
Sanne de Bruin, Thomas W. L. Scheeren, Jan Bakker, et al. (2019). Transfusion practice in the non-bleeding critically ill: an international online survey—the TRACE survey. Critical Care, 23(1). https://doi.org/10.1186/s13054-019-2591-6
Related

You May Also Like

Sepsis biomarkers: a review

Charalampos Pierrakos, Jean-Louis Vincent · 2010

1,027 citations

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

Wentao Ni, Xiuwen Yang · 2020

907 citations

Burn wound healing and treatment: review and advancements

Matthew P. Rowan, Leopoldo C. Cancio · 2015

777 citations